Latest European Union News

Euro Manganese has filed comprehensive NI 43-101 and JORC reports for its Chvaletice Manganese Project, confirming robust economics with a base case post-tax NPV of US$492 million and an upside scenario pushing NPV to US$798 million, driven by higher manganese prices.

4DMedical has cleared a major regulatory hurdle with the Therapeutic Goods Administration approving its CT:VQ™ lung imaging software, paving the way for commercial use across Australia and strengthening its global footprint.

Kingston Resources launches a $8.47 million rights issue at a 12.5% discount, backed by a $4.4 million placement, to finance a major drilling campaign and plant expansion at Mineral Hill following the closure of its Pearse South open pit.

European Metals Holdings reveals lithium chemical plant design improvements at Cinovec that could slash reagent and power costs by over US$54 million annually, potentially boosting the project’s pre-tax NPV beyond US$1.455 billion.

Elementos Limited has secured a key regulatory milestone as the Regional Government of Andalucía grants its Oropesa Tin Project Overriding Public Interest status, easing the path for critical water licensing and advancing permitting certainty.

Viridis Mining hosted European Union Commissioner Jozef Síkela at its Colossus Rare Earth Project in Brazil, marking a key step in forging strategic critical minerals partnerships between Brazil and Europe.

Osmond Resources has expanded the high-grade heavy mineral zone at its Orión EU Critical Minerals Project in Spain, with drill hole SOR-08 intersecting key quartzite layers 1.25km from prior discoveries. This development supports the maiden Mineral Resource Estimate and keeps the company on track for a Q3 2026 Scoping Study.

Kingston Resources stops mining at Pearse South after a second geotechnical failure, pivoting to a major underground drilling program and launching a $11.6 million capital raise to underpin a long-term expansion at Mineral Hill.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Diamond Infraco has officially satisfied multiple regulatory conditions in its takeover offer for Atlas Arteria, freeing the offer from several major hurdles and holding a 34.56% stake.

Cynata Therapeutics secures a crucial regulatory green light from the EMA’s Paediatric Committee for its CYP-001 treatment in children with acute graft versus host disease, paving the way for sequential adult and paediatric trials in Europe.

Cadoux Ltd has cleared a critical technical and commercial hurdle by qualifying its premiumHPA® high purity alumina for use in the EU-backed SAFELOOP electric vehicle battery project, opening doors to potential offtake deals and boosting its standing in the critical minerals market.